YUHWA LO, Ph.D.
Head Scientific Advisor
Dr. Lo is the lead inventor of this technology. As a Professor of Electrical Computer Engineering at UCSD, Dr. Lo heads a team of 17 Ph.D and Postdoc researchers where their focus is on biomedical devices and systems, bioelectronics, microfluidics, nanophotonics, and semiconductor nanoscaled devices. He also serves as the Director of the Nano3 Facility (Nanoscience, Nanoengineering, and Nanomedicine). Dr Lo has published nearly 400 technical papers, 10 book chapters, been awarded 26 patents and has spun-out several technologies from his lab that have been commercialized.
ROBERT THOMPSON, MBA
Currently CEO of Emerge Diagnostics, Robert has been CEO of 2 previous venture-backed firms that achieved considerable shareholder value with their exits. Robert has been employed at the "C" level for over 20 years and brings a great deal of operational experience in growing small biotech companies to exit. As the CEO, he architected the sale of eScreen to Allere.
JOHN RADAK, MBA
Financial &Strategic Advisor
Currently CFO at publicly traded ArborGen, Inc., John is a well respected Wall Street CFO with public and private experience at global, mid-size medical, manufacturing, life sciences, CPG, technology and ecommerce companies. John has had similar positions at Quidel and Life Technologies and is known for transforming businesses to create value.
ALEXANDER KHALESSI, MD, MS
A board-certified neurosurgeon, Dr. Khalessi is also an associate Professor of Surgery and Neurosciencesat the University of California @ San Diego. Dr. Khalessi is the vice chairman of clinical affairs, the director of endovascular neurosurgery and surgical director of neurocritical care. Dr. Khalessi is the only neurosurgeon to serve on the Interventional Advisory Panel for the StrokeNetSteering Committee and also leads the National Football League's (NFL) Unaffiliated Neurotrauma Consultant (UNC) Program in the Southern California region.